drugset / Trial / NCT05070156
B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
This is an Open-label, Single Arm study to observe the safety and tolerability of B010-A in the treatment of advanced hepatocellular carcinoma.
Timeline
- Start
- 2021-10-29
- Primary completion
- 2024-08-31
- Completion
- 2024-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | B010-A | Cell therapy | 100000 cells/kg | — |
| Subject | B010-A | Cell therapy | 200000 cells/kg | — |
| Subject | B010-A | Cell therapy | 300000 cells/kg | — |